Literature DB >> 12665681

Liver metastasis at the time of initial diagnosis of lung cancer.

Katsunori Kagohashi1, Hiroaki Satoh, Hiroichi Ishikawa, Morio Ohtsuka, Kiyohisa Sekizawa.   

Abstract

In order to evaluate clinicopathological features associated with liver metastases from lung cancer, we reviewed our experience of lung cancer patients seen in our division. Of the 1073 lung cancer patients diagnosed between October 1976 and May 2002, 62 (5.8%) patients had liver metastasis. The incidence of liver metastasis was 17.5% in small-cell lung cancer (SCLC) patients, whereas the incidence in non-small-cell lung cancer patients was 3.8%. Of the 62 patients, 17 had sole liver metastasis, and the remaining 45 had synchronous spread to the liver and one or more other organs. Six of 12 squamous cell carcinoma patients and 10 of 28 SCLC patients had sole liver metastasis. However, 19 of 20 adenocarcinoma patients showed liver metastasis with one or more other organs. In morphological liver metastasis, 26 of the 28 SCLC patients had multiple nodules, whereas 16 of the 34 non-small-cell lung cancer patients had a solitary liver nodule (p = 0.0006). Liver is a possible site of extrathoracic spread of disease for some patients with lung cancer, especially with SCLC. When the histological types are squamous cell carcinoma or SCLC, it would also be considered likely that an isolated liver mass represents a metastasis even though there is no metastatic disease elsewhere.

Entities:  

Mesh:

Year:  2003        PMID: 12665681     DOI: 10.1385/MO:20:1:25

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  18 in total

1.  Repeat hepatectomy for recurrent hepatic metastases from colorectal cancer.

Authors:  H Yamada; H Katoh; S Kondo; S Okushiba; T Morikawa
Journal:  Hepatogastroenterology       Date:  2001 May-Jun

2.  Diagnostic accuracies of clinical studies in patients with small cell carcinoma of the lung.

Authors:  L Y Chak; S B Paryani; B I Sikic; P Lockbaum; F M Torti; S K Carter
Journal:  J Clin Oncol       Date:  1983-05       Impact factor: 44.544

3.  Extrahepatic biliary obstruction caused by small-cell lung cancer.

Authors:  D H Johnson; J D Hainsworth; F A Greco
Journal:  Ann Intern Med       Date:  1985-04       Impact factor: 25.391

4.  Metastatic pattern in non-resectable non-small cell lung cancer.

Authors:  L E Stenbygaard; J B Sørensen; H Larsen; P Dombernowsky
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

5.  Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer.

Authors:  F Tas; A Aydiner; E Topuz; H Camlica; P Saip; Y Eralp
Journal:  Acta Oncol       Date:  1999       Impact factor: 4.089

6.  Metastatic pattern in adenocarcinoma of the lung. An autopsy study from a cohort of 137 consecutive patients with complete resection.

Authors:  L E Stenbygaard; J B Sørensen; J E Olsen
Journal:  J Thorac Cardiovasc Surg       Date:  1995-10       Impact factor: 5.209

7.  Metastatic small cell lung cancer causing biliary obstruction.

Authors:  M Obara; H Satoh; Y T Yamashita; H Kamma; M Ohtsuka; S Hasegawa; K Orii
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

8.  Liver metastasis in cancer of the stomach and its dependence on the histology of the primary tumor: an autopsy study on 102 cases.

Authors:  W Rhomberg; U Gruber
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

9.  Surgical treatment for gastric carcinomas with concomitant hepatic metastasis.

Authors:  A Saito; D Korenaga; Y Sakaguchi; S Ohno; Y Ichiyoshi; K Sugimachi
Journal:  Hepatogastroenterology       Date:  1996 May-Jun

10.  Fulminant hepatic failure caused by diffuse intrasinusoidal metastatic liver disease: a case report.

Authors:  O Martelli; L Coppola; A L De Quarto; M Palma; R Sarmiento; C M Foggi
Journal:  Tumori       Date:  2000 Sep-Oct
View more
  22 in total

1.  Differences in clinical presentation of non-small cell lung cancer in never-smokers versus smokers.

Authors:  Joo Young Lee; Im Ii Na; Seung-Hun Jang; Yong Il Hwang; Du Hwan Choe; Cheol Hyeon Kim; Heejong Baek
Journal:  J Thorac Dis       Date:  2013-12       Impact factor: 2.895

2.  Specific organ metastases and survival in metastatic non-small-cell lung cancer.

Authors:  Tomohiro Tamura; Koichi Kurishima; Kensuke Nakazawa; Katsunori Kagohashi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Mol Clin Oncol       Date:  2014-09-04

3.  EUS-B-FNA for Diagnosing Liver and Celiac Metastases in Lung Cancer Patients.

Authors:  Ida Skovgaard Christiansen; Uffe Bodtger; Therese Maria Henriette Naur; Khaliq Ahmad; Jatinder Singh Sidhu; Rafi Nessar; Goran Nadir Salih; Asbjørn Høegholm; Jouke Tabe Annema; Paul Frost Clementsen
Journal:  Respiration       Date:  2019-09-27       Impact factor: 3.580

4.  Trimodal Therapy: Combining Hyperthermia with Repurposed Bexarotene and Ultrasound for Treating Liver Cancer.

Authors:  Manas R Gartia; Zhe Wu; Arun K De; Mao Ye; Santosh K Misra; Goutam Ghoshal; Corinne R Bromfield; Emery M Williams; Kuldeep Singh; Krishnarao V Tangella; Laurie Rund; Klaus Schulten; Lawrence B Schook; Partha S Ray; Everette C Burdette; Dipanjan Pan
Journal:  ACS Nano       Date:  2015-10-12       Impact factor: 15.881

5.  Lung fluorescence imaging to evaluate tumor metastasis induced by AQP5 expression in murine model.

Authors:  Zi-qiang Zhang; Zhu-xian Zhu; Chun-xue Bai
Journal:  Med Oncol       Date:  2010-12-31       Impact factor: 3.064

Review 6.  Yttrium-90 microspheres: a review of its emerging clinical indications.

Authors:  Natthida Khajornjiraphan; Nyein Aye Thu; Pierce Kah Hoe Chow
Journal:  Liver Cancer       Date:  2015-03       Impact factor: 11.740

7.  Specific organ metastases and survival in small cell lung cancer.

Authors:  Kensuke Nakazawa; Koichi Kurishima; Tomohiro Tamura; Katsunori Kagohashi; Hiroichi Ishikawa; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Oncol Lett       Date:  2012-07-09       Impact factor: 2.967

8.  A spontaneous metastasis model reveals the significance of claudin-9 overexpression in lung cancer metastasis.

Authors:  Rajesh K Sharma; Zinal S Chheda; Biswa Pratim Das Purkayastha; Jorge G Gomez-Gutierrez; Venkatakrishna R Jala; Bodduluri Haribabu
Journal:  Clin Exp Metastasis       Date:  2015-12-15       Impact factor: 5.150

9.  Fragmentation of Small-Cell Lung Cancer Regulatory States in Heterotypic Microenvironments.

Authors:  Dylan L Schaff; Shambhavi Singh; Kee-Beom Kim; Matthew D Sutcliffe; Kwon-Sik Park; Kevin A Janes
Journal:  Cancer Res       Date:  2021-02-02       Impact factor: 13.312

10.  Yttrium-90 microsphere radioembolization for treatment of lung cancer hepatic metastases.

Authors:  Ron C Gaba; Janesh Lakhoo
Journal:  Case Rep Oncol       Date:  2012-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.